like aryx more for the AF and Propulsid look a likes, and the fact that they can seem to use their platform to make numerous more drugs that have blockbuster potential
To buy the stock here you have to really believe this enhanced warfarin will beat warfarin in the current trial. This is the drug I have my most doubts about.
If this trial fails then you buy the stock with both hands because the AF drug will garner good partnership terms in my opinion.
Any comments on how SNY's Multaq, which was approved today for AF, stacks up against ARYX's AF compound?
Market Data 
Markets 
AI
